FDA approves Merck pneumococcal disease vaccine designed for adults
Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said.Merck's shot, called Capvaxive, specifically protects...